×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Why Endocyte, Inc. Stock Is Soaring Today
Yahoo Movies UK
Shares of cancer specialist Endocyte (NASDAQ: ECYT) rose by as much as 51.3% in pre-market trading this morning. The catalyst?
1 week ago
Endocyte becomes first Purdue startup to reach $1.5B in value
Purdue University
Endocyte becomes first Purdue startup to reach $1.5B in value. Endocyte's primary cancer drug platforms include “two of the most exciting...
68 months ago
Why Endocyte Stock Is on the Move Today
Yahoo Movies UK
Shares of the clinical-stage biotech Endocyte (NASDAQ: ECYT) are on the move yet again today on heavier than normal volume.
1 week ago
ASCO: Novartis backs up $2.1B Endocyte buyout with prostate cancer data
Fierce Biotech
More than two years after splashing out $2.1 billion on Endocyte, Novartis is pulling the curtain on full phase 3 data for the...
36 months ago
Novartis: Endocyte Spikes 50% on $2.1 Billion Deal
Business Insider
Endocyte, a US cancer-treatment provider, entered into a deal on Thursday to be acquired by Swiss drug maker Novartis.
67 months ago
Novartis to Acquire Endocyte for $2.1B, Expanding RLT Pipeline in Prostate Cancer
Genetic Engineering and Biotechnology News
Novartis has agreed to acquire Endocyte for $2.1 billion, the companies said today, in a deal that expands the buyer's radioligand therapy...
67 months ago
Novartis Plunks Down $2.1 Billion for Endocyte
BioSpace
The acquisition of Endocyte comes about a year after Novartis snapped French cancer firm Advanced Accelerator Applications in a $3.9 billion...
67 months ago
Purdue startup Endocyte sold in $2.1B deal with Novartis
Journal & Courier
Endocyte, based in West Lafayette, has been chasing a targeted drug to cure prostate cancer. Novartis deal announced Thursday.
67 months ago
Novartis to acquire Indiana-based Endocyte for $2.1B
Radiology Business
Novartis, a large healthcare company based in Basel, Switzerland, has agreed to acquire Endocyte, a West Lafayette, Indiana-based...
67 months ago
Novartis Plans to Acquire Endocyte to Expand Expertise in Radiopharmaceuticals
Onco'Zine
Novartis Plans to Acquire Endocyte to Expand Expertise in Radiopharmaceuticals ... Earlier this month Swiss-based Novartis announced that it has...
67 months ago